XML 54 R33.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Segment Information (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2024
Segment Reporting [Abstract] |
Disaggregation of Revenue [Table Text Block] | The following tables present revenue for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
| Three Months Ended March 31,
(in millions) | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 50,651 |  |  | $ | 46,496 |
Global Medical Products and Distribution | 3,113 |  |  | 2,989 |
Nuclear and Precision Health Solutions | 352 |  |  | 313 |
at-Home Solutions | 743 |  |  | 651 |
OptiFreight® Logistics | 72 |  |  | 61 |
Other | 1,167 |  |  | 1,025 |
Total segment revenue | 54,931 |  |  | 50,510 |
Corporate (1) | (20) |  |  | (23) |
Total revenue | $ | 54,911 |  |  | $ | 50,487 |
| Nine Months Ended March 31,
(in millions) | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 154,524 |  |  | $ | 139,441 |
Global Medical Products and Distribution | 9,264 |  |  | 9,140 |
Nuclear and Precision Health Solutions | 1,006 |  |  | 875 |
at-Home Solutions | 2,188 |  |  | 1,986 |
OptiFreight® Logistics | 198 |  |  | 177 |
Other | 3,392 |  |  | 3,038 |
Total segment revenue | 167,180 |  |  | 151,619 |
Corporate (1) | (61) |  |  | (60) |
Total revenue | $ | 167,119 |  |  | $ | 151,559 |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block] | The following tables present revenue by geographic area:
| Three Months Ended March 31,
(in millions) | 2024 |  | 2023
United States | $ | 53,715 |  |  | $ | 49,343 |
International | 1,216 |  |  | 1,167 |
Total segment revenue | 54,931 |  |  | 50,510 |
Corporate (1) | (20) |  |  | (23) |
Total revenue | $ | 54,911 |  |  | $ | 50,487 |
| Nine Months Ended March 31,
(in millions) | 2024 |  | 2023
United States | $ | 163,548 |  |  | $ | 148,186 |
International | 3,632 |  |  | 3,433 |
Total segment revenue | 167,180 |  |  | 151,619 |
Corporate (1) | (61) |  |  | (60) |
Total revenue | $ | 167,119 |  |  | $ | 151,559 |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment | The following tables present segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
| Three Months Ended March 31,
(in millions) | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 580 |  |  | $ | 560 |
Global Medical Products and Distribution | 20 |  |  | (46) |
Other (1) | 111 |  |  | 106 |
Total segment profit | 711 |  |  | 620 |
Corporate | (344) |  |  | (48) |
Total operating earnings | $ | 367 |  |  | $ | 572 |
| Nine Months Ended March 31,
(in millions) | 2024 |  | 2023
Pharmaceutical and Specialty Solutions | $ | 1,541 |  |  | $ | 1,394 |
Global Medical Products and Distribution | 18 |  |  | (175) |
Other (1) | 319 |  |  | 305 |
Total segment profit | 1,878 |  |  | 1,524 |
Corporate | (1,043) |  |  | (934) |
Total operating earnings | $ | 835 |  |  | $ | 590 |
(1)Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight® Logistics.
Assets by Reportable Segment | The following table presents total assets for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions) | March 31, 2024 |  | June 30, 2023
Pharmaceutical and Specialty Solutions | $ | 30,496 |  |  | $ | 27,615 |
Global Medical Products and Distribution | 7,357 |  |  | 7,961 |
Other (1) | 2,692 |  |  | 2,621 |
Corporate | 5,335 |  |  | 5,220 |
Total assets | $ | 45,880 |  |  | $ | 43,417 |
(1)Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight® Logistics.

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration